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This work aims at comparing alterations in the proteomes of human epithelial ovarian cancer xenografts between stressed and 
non-stressed immunodeficient mice as well as exploring the molecular mechanisms linking chronic psychological stress to 
ovarian cancer oncogenesis and progression. SK-OV-3 cells were injected subcutaneously into nude mice. The stress group 
was subjected to a chronic physical restraint protocol for 6 h on 35 consecutive days, while the control group was unrestrained. 
All mice were sacrificed on day 36 after SK-OV-3 cell injection, and tumors were excised. Tumor tissues were processed for 
2D gel electrophoresis, mass spectrometry (nanoUPLC-ESI-MS/MS) and Western blotting. The expression of 20 proteins was 
found to be significantly altered between the stress and control groups, of which 14 were up-regulated, five were 
down-regulated, and one protein was found only in the stress group. All proteins were identified by UPLC-ESI-MS/MS, and 
Western blotting results were consistent with those of proteomic methods. The present results provide new evidence relating to 
the molecular mechanism underlying the relationship between psychological stress and tumor progression. 
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With the development of integrated treatment, remarkable 
achievements have been made in combating cancer. How-
ever, ovarian cancer, as the second most common malig-
nancy of the reproductive system in women [1], remains 
extremely difficult to diagnose in its early stages. Most 
women with ovarian cancer have no, or only non-specific, 
symptoms. Upon diagnosis, approximately 70% of patients 
are already at the advanced stage. Therefore, ovarian cancer 
is still the leading cause of mortality among gynecological 
cancers, with the five-year survival rate being only 
19%–39% [2]. Because patients suffer both mental and 
physical stress, they may find the rigors of therapy very 
daunting. This additional stress may seriously affect the 
prognosis. 
Significant advances in medicine have led from the single 
biomedical model of treatment to a more integrated biopsy-
chosocial model. Factors such as socio-economic status, life-
style, personality, and emotional and psychological factors 
are now taken into consideration in addition to the patho-
logical, biological, genetic and biochemical etiology of the 
disorder. Clinicians and researchers alike now pay close 
attention to the effects of psychosocial factors on tumor 
patients. Studies suggest that psychosocial factors affect the 
immune system primarily through dysfunction of the hypo-
thalamus-pituitary-adrenal axis. Thus, these factors affect 
the occurrence and prognosis of cancer [3,4]. However, 
most of the clinical and experimental research to date is 
limited to the effects on neuroendocrine and immune func-
tion. The molecular mechanisms underlying these effects 
are rarely defined, and there are, to our knowledge, no stud-
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ies that have reported differences in tumor protein in re-
sponse to psychosocial disturbances. 
Proteomic analysis, providing global protein information, 
is of great virtue for oncological studies. Tumor-associated 
proteomics is feasible and practicable to the investigation of 
oncogenesis, screening of cancer biomarkers, early diagno-
sis and treatment of cancer and assessment of prognosis [5]. 
Proteomic analysis allows comparisons to be made between 
protein expression patterns in different tissues/cells or fluc-
tuations in protein expression elicited by different pharma-
ceutical or psychological treatments. These proteins can 
subsequently be used as potential biomarkers for monitoring 
studies, and help in drawing conclusions regarding the mo-
lecular mechanisms by which certain diseases arise and 
progress. Recently, some progress has been made using 
comparative proteomic studies to investigate ovarian cancer 
[2,6–13]. Several studies have reported hippocampus pro-
teome changes after chronic psychological stress [14–16]. 
However, little is known about the effects of chronic psy-
chological stress on the proteome of ovarian cancer tissue. 
Using comparative proteomics methods, we have estab-
lished a subcutaneous xenotransplanted tumor model of 
human epithelial ovarian cancer in nude mice and created a 
restraint model of chronic psychological stress. We then used 
high resolution two-dimensional electrophoresis (2-DE) to 
delineate the patterns of protein expression in the graft tu-
mor. Proteins that were differentially expressed between 
stress and non-stress ovarian cancer tissue were identified by 
ultra-high-performance liquid chromatography-electrospray 
ionization tandem mass spectrometry (UPLC-ESI-MS/MS). 
Our aim is to investigate the molecular mechanism by 
which chronic psychological stress affects ovarian cancer 
oncogenesis and development, which will hopefully lead to 
better psychological and molecular treatment strategies. 
1  Materials and methods 
1.1  Chemicals 
RPMI 1640 and fetal bovine serum (FBS) were obtained 
from Hyclone Corporation (USA). Sodium dodecyl sulfate 
(SDS), dithiothreitol (DTT), Tris (Tris-(hydroxymethyl)-      
aminomethane), bromophenol blue, ammonium persulfate 
(APS), glycine, acrylamide, Immobiline Dry-Strips (3–10 
L), immobilized pH gradient (IPG) buffer, Drystrip cover 
fluid, agarose, urea, Coomassie brilliant blue G-250, and 
2-D SDS-PAGE standards were purchased from Amersham 
Pharmacia Biotech AB (Uppsala, Sweden). Dimethyl sul-
foxide (DMSO), bovine serum albumin (BSA) trifluoroace-
tic acid (TFA), N,N′-methylene-bis-acrylamide, N,N,N′,N′-    
tetramethylethylenediamine (TEMED), Iodoacetamide (IAA), 
3-[3-(cholamidopropyl) dimethylammonio]-1-propanesu- 
lfonate (CHAPS), protease inhibitor cocktail, and trypsin 
were purchased from Sigma Corporation (USA). DNase, 
RNase, anhydrous sodium acetate, anhydrous sodium car-
bonate, silver nitrate, thiosulfate sodium, glutaraldehyde, 
ethanol, glacial acetic acid, methanol, acetonitrile (ACN), 
glycerol, formaldehyde, and Tween 20 (analytical grade or 
chromatography pure) were all obtained domestically. All 
buffers were prepared with Milli-Q purified water (Milli-
pore, USA). 
1.2  Instruments 
The UV-160 spectrophotometer was purchased from Shima-
dzu Corporation (Japan). The IPGphor isoelectric focusing 
system, image scanner, constant temperature circulator, im-
age analysis software (ImageMaster 2D Platinum™) were 
purchased from Amersham Pharmacia Biotech AB (Sweden). 
The Protean IIxi™ cell SDS-PAGE electrophoresis system 
was purchased from BIO-RAD Ltd. (USA). The nanoUPLC-     
ESI-MS/MS system was purchased from Waters (USA). 
1.3  Cell line and animals 
The human ovarian cancer cell line, SK-OV-3, was obtained 
from the Institute of Biochemistry and Cell Biology, 
Shanghai Institute of Biological Sciences, Chinese Acad-
emy of Sciences, China in March 2009. DNA fingerprinting 
using short tandem repeats was applied as a characterization 
method, as previously described [17]. Cells were main-
tained in RPMI-1640 medium supplemented with 10% 
heat-inactivated fetal bovine serum and penicillin-strepto-      
mycin (50 U mL−1) at 37°C in a humidified atmosphere of 
5% CO2 and 95% air, as previously described [18]. Cells in 
the exponential growth phase were harvested with trypsini-
zation, washed in Hank’s solution and ice-cold PBS, and 
counted. After resuspension at 2×107 cells mL−1 in se-
rum-free RPMI-1640, 100 μL (2×106 cells) was injected 
subcutaneously into mice. Female BALB/c-nu mice (4–6 
weeks old) were purchased from the Laboratory Animal 
Research Center of Hubei Province (China), and housed in 
laminar air flow cabinets under pathogen-free conditions 
with a 12-h light/12-h dark schedule and fed autoclaved 
standard chow and water ad libitum [19]. All experiments 
on mice were conducted in accordance with the guidelines 
of the National Institutes of Health for the Care and Use of 
Laboratory Animals. The study protocol was also approved 
by the Animal Ethics Committee of the Medical College of 
Nanchang University. 
1.4  Tumor xenograft and chronic restraint stress 
Mice were divided randomly into stress and control groups 
after a week in the new environment (six mice per group). 
For the chronic restraint stress group, mice were subjected 
to an established chronic physical restraint protocol [20,21], 
in which they were restrained daily for 6 h (from 11 a.m. to 
5 p.m.) in a 50 mL conical centrifuge tube filled with multi-
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ple punctures to allow ventilation, food and water, which 
were provided only during the stress interval. The mice 
were neither physically compressed nor experiencing pain. 
SK-OV-3 was injected subcutaneously into both stress and 
control group mice on the right lateral chest wall in close 
proximity to the axilla [22] on day 8 after starting the stress 
protocol. Stress group mice were exposed to stress for 6 h 
per day for 35 consecutive days after tumor xenograft, while 
control littermates were kept in their original cage. All mice 
from each group were sacrificed by cervical dislocation on 
day 36 after SK-OV-3 injection, and tumors were removed. 
The entire tumor mass was carefully dissected (excluding 
any extraneous host tissue), cleaned of clots, immersed in 
liquid nitrogen immediately after resection and stored at 
−80°C until analysis. 
1.5  Protein extraction 
Frozen xenografts tissue samples were ground in liquid ni-
trogen, and homogenized on ice by using a glass tissue 
grinder. For every 100 mg tissue, 1 mL lysis buffer (con-
sisting of 40 mmol L−1 Tris buffer (pH 7.5), 7 mol L−1 urea, 
2 mol L−1 thiourea, 1% DTT, 4% CHAPS, and 1 mmol L−1 
EDTA) and 10 μL protease inhibitor cocktail were added. 
The homogenates were sonicated (10 bursts of 5 s, sepa-
rated by 15 s intervals) on ice using a Digital Sonifier. After 
sonication, 5 μL of 10 μg μL−1 DNase and 5 μL 10 μg μL−1 
RNase were added. Subsequently, the sample was incubated 
for 20 min on ice. Cellular debris was removed by centrifu-
gation at 14000 r min−1 for 20 min at 4°C, and the super-
natants were collected. The protein concentrations were 
quantified by Bradford protein concentration assay. Global 
protein samples were sub-packaged, labeled and stored at 
−80°C until 2-DE analysis. 
1.6  Two-dimensional electrophoresis 
Protein samples (100 µg) were mixed with rehydration solu-
tion (8 mol L−1 urea, 2% CHAPS, 0.5% IPG buffer, 18 
mmol L−1 DTT and a trace of bromophenol blue) to a vol-
ume of 350 µL. This sample was loaded into strip holders 
together with 18 cm Immobiline DryStrips (linear pH gra-
dient from pH 3 to 10), and the loaded strips were covered 
with Drystrip Cover fluid. The rehydration holders were 
placed in the IPGphor IEF system for passive rehydration 
for 12 h at 30 V at 20°C. Subsequently, isoelectric focusing 
on the first dimension was carried out. The proteins were 
focused at 20°C for 1 h at 500 V, then 1 h at 1000 V, and 
finally 6 h at 8000 V. After completion of the IEF program, 
the strips were equilibrated at room temperature in two 
steps: 15 min in an IPG equilibration buffer (50 mmol L−1 
Tris-HCl solution (pH 8.8), 6 mol L−1 urea, 30% glycerol, 
2% SDS, and a trace of bromophenol blue) plus 1% DTT, 
followed by 15 min in IPG equilibration buffer plus 2.5% 
IAA. For the second dimension, SDS-PAGE with a 13% 
polyacrylamide gel was used. The IPG strips were placed on 
the top of gel and the proteins were then separated accord-
ing to their molecular weights. Electrophoresis was carried 
out at 20°C, 15 mA/gel for 15 min, followed by a 6 h run at 
30 mA/gel until the bromophenol blue indicator front 
reached the bottom of the gels. Three 2-DE gels were per-
formed for each group.  
1.7  Gel scanning and image analysis 
After silver staining, the 2-D gels were imaged on an Image 
Scanner in a transmission mode, and quantitative analyses 
of the digitized images were performed using the Image 
Master 2D PlatinumTM software according to the protocols 
provided by the manufacturer, which included background 
subtraction, spot detection, defining landmark annotations, 
and matching. The intensity of each spot was normalized to 
the total valid spot intensity. Gels from the control and 
stress group were analyzed simultaneously. Each sample 
was analyzed based on triplicate gels produced in identical 
conditions to demonstrate reproducibility and diminish ex-
perimental errors. An average gel would be selected as a 
standard gel in each group by matching analysis, with more 
homogeneous spots, fewer impurities and better representa-
tion of the spot distribution. Using image analysis software, 
target spots were compared to the average gel to detect in-
creases/decreases in expression (to more than double/half 
that of control, respectively), and to catalogue significant 
inter-group variations. 
1.8  Protein identification by nanoUPLC-ESI-MS/MS 
Considering its compatibility to nanoUPLC-ESI-MS/MS 
analysis, we chose Coomassie Brilliant Blue G-250 staining 
in this study. We selected the preparative gels to perform 
Coomassie Brilliant Blue G-250 staining. Differentially 
expressed protein spots were selected, which were chosen 
according to the spots of silver staining gels. Twenty target 
spots were carefully excised from gels using a biopsy scal-
pel, and spot pieces were digested with trypsin in a 1.5 mL 
siliconized Eppendorf tube. Spot pieces were washed twice 
with Milli-Q water, destained in 50% ACN containing 100 
mmol L−1 ammonium bicarbonate for 20 min at room tem-
perature, dehydrated and dried using a vacuum centrifuge. 
The dried gel pieces were incubated in 50 mmol L−1 ammo-
nium bicarbonate containing 0.1 μg μL−1 modified trypsin 
for digestion at 37°C overnight (12–16 h). The resulting 
harvested peptide mixture was prepared into a sample solu-
tion as described previously [23]. Sample solution (5 μL) 
was injected into a nano-Acquity system and subjected to 
nanoUPLC-ESI-MS/MS analysis. The UPLC-ESI-MS/MS 
system consists of a nano-ACQUITY UPLC system and a 
Synapt high definition mass spectrometer using an electros-
pray ionization source Z-spray. The ACQUITY UPLC ana-
lytical column uses a 75 μm×250 mm BEH C18 column 
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packed with 1.7 μm particles, and the enrichment column is 
a 180 µm×20 mm symmetry C18 packed with 5 µm parti-
cles. The column temperature was maintained at 35°C. Op-
timum separation was achieved with a gradient mobile 
phase (which flowed at a rate of 200 nL min−1) and two 
mobile phases consisting of 0.1% formic acid in water and 
0.1% formic acid in ACN. The gradient conditions are 80 
min 1%–40% B, 10 min 40%–80% B, 10 min 80% B, and 
20 min 100% B, then return to initial conditions. For 
ESI-MS/MS, ionization was achieved by using nano-elec-     
trospray ionization positive ions with a capillary voltage of 
2.5 kV and a cone voltage of 35 V, the source temperature 
and desolvation temperature being set at 90 and 300°C, re-
spectively. Nitrogen was used as the cone gas and for desol-
vation, with a flow rate of 50 and 500 L h−1, respectively. 
Argon was used as the collision gas set at 2.5×10−3 mbar. 
Data were acquired in data dependent acquisition (DDA) 
mode, and the two highest intensity ions were selected from 
each scan, which was carried out using tandem mass spec-
trometry. MS/MS spectra were processed using total data 
acquisition software (PLGS, v2.3), and then analyzed with 
the Mascot search engine (www.matrixscience.com) against 
the NCBInr database including two variable modifications: 
Carbamidomethyl (C) and Oxidation (M). One missed 
cleavage site was allowed for trypsin digestion, all mass 
values were considered monoisotopic, and the MS/MS tol-
erance was set at ±0.2 Da. Individual ion scores of >38 in-
dicate identity or extensive homology (P<0.05). 
1.9  Western blotting analysis 
For Western blotting, the method was essentially as previ-
ously described [24]. Briefly, protein extracts were sepa-
rated on SDS-PAGE and then blotted to polyvinylidene 
difluoride (PVDF) membranes (Millipore, USA). After in-
cubating for 1 h with PBS containing 0.1% Tween 20 and 
5% non-fat dried milk, primary antibodies were added and 
the membrane was incubated at room temperature overnight. 
Primary antibodies in this study are rabbit anti-peroxire-    
doxin 1 (Millipore, USA), rabbit anti-Cu/Zn superoxide 
dismutase (Alexis-Bio, USA), rabbit anti-nm23 (Millipore, 
USA), rabbit anti-creatine kinase MM (ABCAM, UK) and 
glutathione-S-transferase omega 1 mouse polyclonal anti-
body (ABCAM, UK). After washing, goat anti-rabbit and 
goat anti-mouse horseradish peroxidase-conjugated secon-
dary antibody (ZSGB, China) were added, depending on the 
species of the primary antibody. After incubation for 1 h, 
membranes were decolorized with PBS at room temperature, 
subjected to enhanced chemiluminescence, and exposed to 
film. The exposed films were examined visually and photo-
graphed or scanned. 
1.10  Statistical methods 
To test differences in mouse body weight, xenograft weight 
and fold-change of protein expression between the stress 
and control group, t-tests were used (Statistical Package For 
SSPS17.0). P<0.05 was regarded as statistically significant.  
2  Results 
2.1  Mouse body weight and xenograft weight 
Mouse body weight in the stress group was significantly 
lower than that in the control group after the experiment 
((21.17±2.02) g vs. (24.52±0.67) g, respectively; n=6; P<    
0.01), whereas there was no difference in body weight be-
tween the stress and control groups prior to the experiment 
((18.58±1.07) g vs. (18.42±0.86) g, respectively; n=6; P>    
0.05). The subcutaneous nodules began to emerge 4 d after 
SK-OV-3 injection, and xenografts began to grow rapidly 
10 d after SK-OV-3 injection. Average xenograft weight in 
the stress group was significantly higher than that in the 
control group ((1.72±0.57) g vs. (1.08±0.29) g; P<0.05). 
2.2  Overview of protein profiles of xenograft 
Three mice were randomly selected from each of the stress 
and control groups, and a single 2-D gel was prepared from 
each mouse. On average, 1467 protein spots were detected 
in stress group 2-DE profiles compared to 1292 in the con-
trol group (Figure 1). We found that matching ratios 
reached 92.1% (control-), 89.4% (stress-) and 82.4% (in-
ter-group), which indicated ideal reproducibility of these 
images (>75% being considered as good). With the image 
analysis software, we found that 19 protein spots were ex-
pressed at significantly different levels in the stress group to 
the respective spots from the control group (14 were 
up-regulated, five were down-regulated) and one protein 
spot was found only in the stress group (Figures 2–4).  
2.3  Results of protein identification 
Twenty target protein spots were submitted for identifica-
tion using UPLC-ESI-MS/MS analysis and NCBInr data-
base searches. All were successfully identified. Fourteen 
proteins were up-regulated, including peroxiredoxin 1, 
laminin-binding protein, 14-3-3 protein epsilon isoform, 
nm23 protein, and phosphoglycerate kinase 1. Five proteins 
were down-regulated, including N-myc downstream regu-
lated 1, muscle creatine kinase and myosin light chain 2. 
The protein found only in the stress group gels has been 
identified as SET protein. Full results of the UPLC-ESI-     
MS/MS analysis are listed in Table 1. 
2.4  Western blotting analysis 
The results showed that Prdx1, SOD1, GSTO1 and Nm23 
protein expression in the stress group xenograft tissue was  
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Figure 1  Representative 2-DE gels of human epithelial ovarian cancer xenograft proteins from immunodeficient mice in the psychological stress group (A) 
and the control group (B). Whole xenograft protein was separated by 2-DE and visualized by silver staining. Protein spots that were altered by psychological  
stress are labeled by numbers. The molecular weights (MW) and pI scales are indicated. 
higher than that in the control group, while creatine kinase 
MM protein expression level was significantly reduced 
(Figure 5), in agreement with the results of the proteomic 
analyses. 
3  Discussion 
Psychological factors have been shown to influence the on-
cogenesis and prognosis of ovarian cancer. Development 
and progression of ovarian cancer is a complex process in-
volving multiple genes and signaling pathways. However, 
its mechanism of action remains unclear because a compre-
hensive study of the relationship between psychology and 
tumor development, and the prevention of tumor occur-
rence/growth by means of psychological factors, has yet to 
be performed. Because psychological factors are hard to 
control, we chose to study the effect of psychological stress 
on tumor development using animal models of chronic 
stress, which have better reproducibility/controllability, a 
short observation cycle and clearer results. The present 
study details a proteomic analysis of molecular changes in 
human epithelial ovarian cancer xenografts in nude mice 
exposed to chronic psychological stress. The study may 
have revealed novel proteins and signaling pathways in-
volved in psychological stress and tumor development.   
In this study, immunodeficient mice bearing human 
epithelial ovarian cancer cells were exposed to chronic re-
straint stress for 6 h d−1 for 35 consecutive days. Global 
protein extract was obtained from xenograft and analyzed 
by 2-DE and nanoUPLC-ESI-MS/MS. Twenty proteins 
were found to have been altered significantly between the 
stress and control groups. Most of them appeared to be in-
volved in physiological processes, such as energy metabo-
lism, cell proliferation, invasion and apoptosis.  
Prdx1 and Prdx3 belong to the superfamily of 
anti-oxidant proteins, which reduce hydrogen peroxide and 
alkyl hydroperoxides. They may play an antioxidant protec-
tive role in cells, and contribute to the antiviral activity of 
CD8(+) T-cells. This protein may have a proliferative effect 
and play a role in cancer development and progression. The 
previous research has shown that a low level of H2O2 pro-
duced by the mitochondria regulates cell proliferation, 
whereas a high level of H2O2 was toxic to the cell and 
caused apoptosis. However, Prdx3-transfected prostate 
cancer cells show a marked resistance to hypoxia-induced 
H2O2 formation and apoptosis [25], suggesting that Prdx3 
overexpression protects cancer cells against apoptosis 
caused by H2O2. Elevation of Prdx1 has been shown in oral, 
pancreatic, follicular thyroid, esophageal, lung, meso-
thelioma, breast, and head and neck cancers [26]. Moreover, 
up-regulation of Prdx1 is implicated in radiotherapy resis-
tance of lung cancer cells and chemotherapy resistance of 
breast cancer, while down-regulation of Prdx1 has been 
shown to sensitize lung cancer cells to radiation [26]. These 
studies suggest that Prdx1 enhances the aggressive survival 
phenotype of cancer cells, and confers an increased resis-
tance to treatment [26]. Up-regulation of Prdx1 and Prdx3 
in the stress group of mice may lead to a disadvantageous 
enhancement of anti-oxidant and anti-apoptosis effects in 
tumor cells. 
Superoxide dismutases (SODs) are responsible for the de-
toxification of superoxide free radicals generated in many 
human organs. In previous studies, SOD2 overexpression has 
been found in cancers of the bladder, breast, gastric tract, and 
prostate, and in acute myeloid leukemia, and is associated  
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Figure 2  Magnified comparison maps of selected protein spots showing up-regulated protein expression in the stress group compared with the control 
group. Spots 1, 2, 3, 4, 5, 6, 7, 9, 15, 16, 17, 18, 19 and 20 were significantly up-regulated (average spot intensity increase higher than two-fold compared  
with the controls) in the psychological stress group (A) at corresponding locations. 
 
Figure 3  Magnified comparison maps of selected protein spots showing 
down-regulated protein expression in the stress group compared with the 
control group. Spots 8, 10, 11, 12 and 14 were significantly 
down-regulated (average spot intensity decrease more than two-fold com-
pared with the controls) in the psychological stress group (A) at corre- 
sponding locations. 
with increased risk for prostate, lung, colorectal, and ovar-
ian cancer [27]. Hirose et al. [28] have shown that increas- 
ing SOD1 level promotes tumor cell survival against 
anti-cancer strategies such as drug therapy and radiation.  
 
Figure 4  Spot 13 has high expression in the stress group (A), but is ab-
sent in the control group (B). 
Moreover, Brown et al. [29] reported SOD1 was a key fac-
tor in acquired cisplatin resistance in ovarian cancer. Hence, 
modulation of its activity can lead to sensitization of cis-
platin-resistant cells, while using an inhibitor of SOD1 has 
been found to attenuate angiogenesis and tumor cell prolif-
eration in vitro. Therefore, we speculate that chronic psy- 
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1 gi|4505591 peroxiredoxin 1 (Prdx1) 22096/8.27 332 36 Up 6.49±0.20 <0.05 
2 gi|1237406 Cu/Zn-superoxide dismutase (SOD1) 15868/5.86 170 34 Up 2.94±0.07 <0.05 
3 gi|34234 laminin-binding protein 31774/4.84 39 10 Up 2.98±0.12 <0.05 
4 gi|14250063 peroxiredoxin 3 (Prdx3) 27705/7.11 269 33 Up 3.31±0.03 <0.05 
5 gi|1313962 mitochondrial ribosomal protein L7L12 (MRPL12) 21365/9.04 67 21 Up 2.17±0.04 <0.05 
6 gi|4758484 glutathione-S- transferase omega 1 (GSTO1) 27548/6.23 507 39 Up 2.23±0.12 <0.05 
7 gi|33413400 esterase D/formylglutathione hydrolase 31442/6.54 339 46 Up 2.09±0.67 <0.05 
8 gi|21536288 muscle creatine Kinase (CKM) 43074/6.77 670 48 Down −(5.98±0.18) <0.05 
9 gi|38503339 superoxide dismutase[Mn], mitochondrial (SOD2) 22190/6.86 311 30 Up 2.56±0.13 <0.05 
10 gi|17986273 fast skeletal myosin alkali light chain 1 isoform 1f 21132/4.97 394 41 Down −(5.59±0.28) <0.05 
11 gi|48762932 chaperonin containing TCP1, subunit 8 (theta) (CCT8) 59583/5.42 134 10 Down −(3.63±0.22) <0.05 
12 gi|37655183 N-myc downstreamregulated 1 (NDRG1) 42808/5.49 736 36 Down −(2.42±0.17) <0.05 
13 gi|338039 Set 32115/4.12 303 36 New  <0.00 
14 gi|1220346 myosin light chain 2 19073/4.91 332 54 Down −(4.52±0.27) <0.05 
15 gi|14277700 ribosomal protein S12 (RPS12) 14505/6.81 159 52 Up 2.88±0.12 <0.05 
16 gi|67464424 14-3-3 protein epsilon isoform 26740/4.92 95 9 Up 3.12±0.10 <0.05 
17 gi|4505753 bisphosphoglycerate mutase 1 (BPGM) 28786/6.67 119 16 Up 4.49±0.22 <0.05 
18 gi|35068 Nm23 protein 20398/7.07 349 33 Up 2.28±0.16 <0.05 
19 gi|4502419 biliverdin reductase B (flavin reductase (NADPH)) 22105/7.13 779 69 Up 3.96±0.10 <0.05 
20 gi|4505763 phosphoglycerate kinase 1 (PGK1) 44586/8.30 404 45 Up 2.50±0.07 <0.05 
a) Individual ions scores >38 indicate identity or extensive homology (P<0.05). b) Up- or down-regulated in the stress group vs. the control group. c) 
Only the fold changes ≥ two-fold are shown. Fold changes for down-regulation ≥ two-fold are denoted by “−”. d) Data were analyzed with an independent 
Student’s t-test with SPSS version 17.0 software, differences were considered significant if P<0.05. 
 
 
Figure 5  Verification of proteins by Western blot analysis. Lane A, stress 
group; Lane B, control group. 
chological stress can also affect DNA repair, drug transport 
of the tumor cell and angiogenic processes. 
BPGM is a homodimer of a subunit that possesses sig-
nificant homology with phosphoglycerate mutase (PGM) 
subunits. Both PGM and PGK1 are involved in the glyco-
lytic cycle and energy metabolism via catalysis reactions in 
the glycolytic pathway. PGM activity levels are signifi-
cantly higher in breast tumor than in corresponding normal 
tissues [30]. Hwang et al. [31] have shown that PGK1 was 
overexpressed in pancreatic ductal adenocarcinoma, while 
Tang et al. [32] have reported that overexpression of PGK-1 
in lung cancer cells reduces COX-2 expression and pro-
motes Th1 immune function. This affects cell invasion, an-
giogenesis, and immune functions, and ultimately inhibits 
tumor progression. In the present study, we have observed 
that it is up-regulated in ovarian cancer tumor following 
restraint stress, suggesting that this protein may be produced 
as part of an anti-tumor protective mechanism. This hy-
pothesis requires further exploration. 
Ribosomes, the organelles that catalyze protein synthesis, 
consist of a small 40S subunit and a large 60S subunit. To-
gether these subunits are composed of four RNA species 
and approximately 80 structurally distinct proteins. In-
creased expression of RPS12 in colorectal cancers com-
pared with matched normal colonic mucosa has been ob-
served, suggesting this event may be an early event in neo-
plastic progression to malignancy [33]. Marty et al. [34] 
have shown that mRNA for MRPL12 (a translational regu-
lator of mitochondrial mRNAs) was highly expressed in the 
colon, in which a reduction in mitochondrial activity (as 
may be expected following disruption of mitochondrial 
protein production) is associated with tumor formation. 
Studies on the relationship between ribosomal proteins and 
ovarian cancer deserve to be further explored. 
nm23 gene is a reported metastasis suppressor gene, but 
the role of nm23 in human ovarian cancer is still controver-
sial. Younl et al. [35] and Schneider et al. [36] have shown 
that nm23 overexpression was an independent factor asso-
ciated with a significantly worse early stage prognosis and 
decreased overall survival in patients with ovarian carci-
noma. Thus, nm23 may have a biological function that leads 
to poor clinical outcomes in ovarian carcinoma. It is unclear 
whether, in the current study, up-regulation of nm23 in the 
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stress group is related to a worse prognosis. 
14-3-3 proteins are a family of dimeric proteins involved 
in many pathways of signal transduction. Seven isoforms 
have been described and various isoforms carry out impor-
tant functions in apoptotic control. 14-3-3 protein epsilon, 
as an anti-apoptotic protein, is up-regulated in tumor fol-
lowing stress exposure. Its function is to activate tyrosine 
and tryptophan hydroxylases in the presence of Ca2+/calmo-      
dulin-dependent protein kinase [37]. However, it is proba-
bly a multifunctional regulator of the cell signaling proc-
esses mediated by both kinases. 
Other proteins that are overexpressed in the stress group 
are involved in the regulation of tumor cell proliferation and 
differentiation. Laminin-binding protein is well-correlated 
with the biological aggressiveness of cancer cells [38]. 
GSTO1 acts as a small stress response protein, which is 
likely involved in cellular redox homeostasis, which con-
trols the conjugation of reduced glutathione to a wide num-
ber of exogenous and endogenous hydrophobic electro-
philes [37]. Esterase D may be involved in the recycling of 
sialic acids, and is used as a genetic marker for retinoblas-
toma and Wilson’s disease [39]. The final step in heme me-
tabolism in mammals is catalyzed by NADPH, which is con-
sidered to be related to drug resistance and anti-apoptosis, 
and plays a role in regulating cellular redox homeostasis and 
signaling pathways [40]. 
Myosin is a hexameric ATPase cellular motor protein. As 
an important member of the cytoskeleton components, the 
myosin family is involved in a number of physiological 
activities, such as morphology maintenance and material 
transportation. This proteomic study has observed signifi-
cant down-regulation of myosin in xenograft tissues after 
stress treatment suggesting that psychological stress effects 
might be associated with cell physiological activities, such 
as destruction of the cytoskeletal system. Zhou et al. [41] 
have shown that reduction of myosin light-chain kinase in 
breast cancer cells was able to suppress cell proliferation 
and migration. Ren et al. [42] have suggested that overex-
pression of myofibrillogenesis regulator 1 is associated with 
cancer cell proliferation and migration mediated by myosin 
light chain 2. These results of previous research are in ap-
parent contradiction, suggesting the need for further re-
search to verify the role of myosin and other cytoskeletal 
proteins in tumor progression. 
Creatine kinase (CK) is a ubiquitous enzyme that cataly-
ses the reversible transphosphorylation reaction between 
ATP and creatine, which plays a key role in the energy me-
tabolism of cells with high and fluctuating energy demands. 
Previous studies have shown that CK activity in neoplastic 
tissue was lower than that of normal tissue when the activity 
is reported as a function of the extracted protein [30]. CCT8 
is a molecular chaperone, and plays an important role in the 
assembly of actin and tubulin, which is significant given 
that a reduction in the number of microtubules is an impor-
tant feature of malignant transformation in cells. Myung et 
al. [43] reported that chaperones were expressed in 10 human 
tumor cell lines. Both CK and CCT8 are down-regulated in 
the stress group, which would give further support to the 
hypothesis that psychological stress affects tumor cell en-
ergy metabolism and the cytoskeletal system. 
NDRG1 was found to be down-regulated in the xeno-
grafts of the stress group compared with the control group. 
NDRG1 has been reported to be necessary for p53-mediated 
apoptosis and it plays a role in suppressing malignant cell 
growth. NDRG1 expression is significantly lower in pa-
tients with lymph node and bone metastasis, and thus 
NDRG1 is thought to function as a metastasis suppressor in 
several cancers, such as colon cancer and esophageal 
squamous cell carcinoma [44,45]. 
set is a putative oncogene associated with myeloid leu-
kemogenesis, and SET protein has been reported as an in-
hibitor of tumor suppressor PP2A in chronic myeloid leu-
kemia [46]. Ouellet et al. [47] have shown that SET com-
plexes were highly expressed in invasive grade 3 serous 
epithelial ovarian cancer. In this study, we found that SET 
protein was only expressed in the stress group. However, 
little is known about this protein and its actions, and further 
study is required before inferring anything about its role in 
cancer progression. 
The present study has indicated that exposure to chronic 
psychological stress might lead to significant changes in the 
proteomic profile of tumors. Expression alterations of those 
proteins might affect tumor cell growth by regulating en-
ergy metabolism, cytoskeletal organization, and cellular 
proliferation, differentiation, and apoptosis. Therefore, the 
present results provide new evidence that could be helpful 
in further understanding the molecular relationship between 
psychological stress and tumor progression. 
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